Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Market Capitalization (2015 - 2026)

Kamada's (KMDA) quarterly Market Capitalization came in at $423.4 million in Q2 2026, down 4.99% on a YoY basis from $445.7 million in Q2 2025, and down 11.99% quarter-over-quarter from $481.1 million in Q1 2026.

Analysis

Kamada (KMDA) Market Capitalization (2015 - 2026) Analysis & Trends

Kamada (KMDA) has reported Market Capitalization for 12 consecutive years, with $423.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Market Capitalization fell 4.99% year-over-year to $423.4 million; the trailing twelve-month figure through Jun 2026 stood at $423.4 million (down 4.99% YoY), and the FY2025 full-year result was $407.3 million, up 16.29% from the prior year.
  • Market Capitalization retreated to $423.4 million in Q2 2026 per KMDA's latest filing, from $481.1 million in the prior quarter.
  • Across five years, Market Capitalization topped out at $481.1 million in Q1 2026 and bottomed at $179.8 million in Q4 2022.
  • Historically, Market Capitalization has averaged $315.0 million across 5 years, with a median of $315.6 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Market Capitalization plunged 39.01% in 2022, then soared 95.67% in 2023.
  • Over 5 years, Market Capitalization stood at $179.8 million in 2022, then jumped by 95.67% to $351.8 million in 2023, then slipped by 0.45% to $350.2 million in 2024, then climbed by 16.29% to $407.3 million in 2025, then grew by 3.97% to $423.4 million in 2026.
  • According to Business Quant data, Market Capitalization over the past three periods registered $423.4 million, $481.1 million, and $407.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 423.42 Mn
Mar 31, 2026 481.10 Mn
Dec 31, 2025 407.26 Mn
Sep 30, 2025 399.08 Mn
Jun 30, 2025 445.66 Mn
Mar 31, 2025 380.11 Mn
Dec 31, 2024 350.21 Mn
Sep 30, 2024 308.67 Mn
Jun 30, 2024 285.10 Mn
Mar 31, 2024 322.46 Mn
Dec 31, 2023 351.77 Mn
Sep 30, 2023 239.41 Mn
Jun 30, 2023 236.49 Mn
Mar 31, 2023 208.25 Mn
Dec 31, 2022 179.78 Mn
Sep 30, 2022 202.05 Mn
Jun 30, 2022 202.05 Mn
Mar 31, 2022 247.29 Mn
Dec 31, 2021 294.78 Mn
Sep 30, 2021 237.14 Mn